Postural Orthostatic tachycardia Syndrome Clinical Trials in Nashville, Tennessee
3 recruitingNashville, Tennessee
Showing 1–3 of 3 trials
Recruiting
Phase 2
Study of Natriuretic Peptide Receptor 1 (NPR1) Antagonist in Adult Patients With Postural Orthostatic Tachycardia Syndrome (POTS)
Postural Orthostatic Tachycardia Syndrome (POTS)
Regeneron Pharmaceuticals81 enrolled18 locationsNCT06593600
Recruiting
Phase 2
Restoring Iron Deficiency in POTS
POTS - Postural Orthostatic Tachycardia Syndrome
Vanderbilt University Medical Center12 enrolled1 locationNCT07197905
Recruiting
Not Applicable
Long COVID Immune Profiling
Autonomic DysfunctionLong COVIDPOTS - Postural Orthostatic Tachycardia Syndrome
Vanderbilt University Medical Center150 enrolled1 locationNCT06027255